AP510A - Therapeutic agent and its use. - Google Patents

Therapeutic agent and its use. Download PDF

Info

Publication number
AP510A
AP510A APAP/P/1993/000555A AP9300555A AP510A AP 510 A AP510 A AP 510A AP 9300555 A AP9300555 A AP 9300555A AP 510 A AP510 A AP 510A
Authority
AP
ARIPO
Prior art keywords
vaccae
aids
material derived
hiv
tuberculosis
Prior art date
Application number
APAP/P/1993/000555A
Other languages
English (en)
Other versions
AP9300555A0 (en
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Publication of AP9300555A0 publication Critical patent/AP9300555A0/xx
Application granted granted Critical
Publication of AP510A publication Critical patent/AP510A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
APAP/P/1993/000555A 1992-09-14 1993-08-05 Therapeutic agent and its use. AP510A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929219425A GB9219425D0 (en) 1992-09-14 1992-09-14 Therapeutic agent and its use

Publications (2)

Publication Number Publication Date
AP9300555A0 AP9300555A0 (en) 1993-10-31
AP510A true AP510A (en) 1996-07-23

Family

ID=10721884

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1993/000555A AP510A (en) 1992-09-14 1993-08-05 Therapeutic agent and its use.

Country Status (17)

Country Link
EP (1) EP0661998B1 (es)
JP (1) JPH06100457A (es)
KR (1) KR100272743B1 (es)
CN (1) CN1060937C (es)
AP (1) AP510A (es)
AT (1) ATE173633T1 (es)
AU (1) AU683835B2 (es)
BR (1) BR9303762A (es)
CA (1) CA2105646A1 (es)
DE (1) DE69322280T2 (es)
DK (1) DK0661998T3 (es)
ES (1) ES2125331T3 (es)
GB (1) GB9219425D0 (es)
RU (1) RU2106878C1 (es)
SG (1) SG72610A1 (es)
WO (1) WO1994006466A1 (es)
ZA (1) ZA935575B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
RU2197989C2 (ru) * 1996-12-18 2003-02-10 Стэнфорд Рук Лимитед ПРИМЕНЕНИЕ Mycobacterium vaccae ДЛЯ РЕГУЛЯЦИИ ПО ТИПУ ОТРИЦАТЕЛЬНОЙ ОБРАТНОЙ СВЯЗИ Th2-АКТИВНОСТИ ИММУННОЙ СИСТЕМЫ
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
GB9903539D0 (en) * 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
GB2382529B (en) * 2001-01-17 2004-01-28 Bakulesh Mafatlal Khamar Use of an immunomodulator for the management of HIV disease/infection
UA77666C2 (en) * 2001-01-17 2007-01-15 Kabulesh Mafatlal Khamar Use of mycobacterium w or its components in preparations for treating hiv infection
CA2474794A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv Indravadan Method of providing prophylaxis for tuberculosis in hiv positive individuals
WO2003063896A1 (en) * 2002-01-29 2003-08-07 Modi, Rajiv, Indravadan Process of preparing a pharmaceutical composition for immunity against tuberculosis in hiv positive individuals
AU2003209534A1 (en) * 2002-03-08 2003-09-22 Bakulesh Mafatlal Khamar The method of treating tuberculosis
RU2380114C1 (ru) * 2008-06-25 2010-01-27 Людмила Анатольевна Шовкун Способ лечения туберкулеза легких у больных вич-инфекцией
JP7760151B2 (ja) * 2021-09-09 2025-10-27 国立大学法人東京海洋大学 抗酸菌症用ｄｎａワクチン及びそれを用いた抗酸菌症の予防方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001751A1 (en) * 1989-07-28 1991-02-21 University College London Biological preparation and its use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3728367C1 (de) * 1987-08-25 1988-09-01 Burkhard Steglich Mittel zur Immunisierung des menschlichen Koerpers bei HIV-Infektionen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001751A1 (en) * 1989-07-28 1991-02-21 University College London Biological preparation and its use

Also Published As

Publication number Publication date
EP0661998A1 (en) 1995-07-12
AU3642093A (en) 1994-04-12
CN1089478A (zh) 1994-07-20
KR100272743B1 (ko) 2000-11-15
AP9300555A0 (en) 1993-10-31
CA2105646A1 (en) 1994-03-15
DE69322280D1 (de) 1999-01-07
ATE173633T1 (de) 1998-12-15
DE69322280T2 (de) 1999-04-22
ES2125331T3 (es) 1999-03-01
BR9303762A (pt) 1994-03-22
JPH06100457A (ja) 1994-04-12
DK0661998T3 (da) 1999-08-09
HK1011289A1 (en) 1999-07-09
RU2106878C1 (ru) 1998-03-20
WO1994006466A1 (en) 1994-03-31
ZA935575B (en) 1994-03-01
GB9219425D0 (en) 1992-10-28
CN1060937C (zh) 2001-01-24
KR950703360A (ko) 1995-09-20
EP0661998B1 (en) 1998-11-25
AU683835B2 (en) 1997-11-27
SG72610A1 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
AU665177B2 (en) Mycobacterium vaccae in the treatment of uveitis
AP510A (en) Therapeutic agent and its use.
AU644813B2 (en) Treatment of chronic inflammatory conditions
US4724144A (en) Immuno-therapeutic composition of killed cells from mycobacterium vaccae
KR100275862B1 (ko) 장기간 자기면역상태의 치료를 위한 미코박테리아 바케
CA2064029C (en) Use of mycobacterium vaccae in the prevention of aids
US6210684B1 (en) Method for delaying the onset of AIDS
HK1011289B (en) Therapeutic agent from mycobacterium vaccae and its use against hiv infection with aids
US6432714B2 (en) Prophylactic and therapeutic method